MAPK8 and idiopathic pulmonary fibrosis: Activated JNK during IPF, accompanied by increased type I collagen secretion, can be significantly inhibited by the JNK-specific inhibitor SP600125, resulting in decreased type I collagen secretion and significant inhibition of extracellular matrix (ECM) processes.